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OBJECTIVES We sought to investigate the clinical impact of balloon angioplasty for native coarctation of
the aorta (CoA) and determine predictors of outcome.
BACKGROUND Balloon dilation of native CoA remains controversial and more information on its long-term
impact is required.
METHODS Hemodynamic, angiographic and follow-up data on 69 children who underwent balloon
angioplasty of native CoA between 1988 and 1996 were reviewed. Stretch, recoil and gain of
CoA circumference and area were calculated and related to outcomes.
RESULTS Initial systolic gradients (mean 6 SD, 31 6 12 mm Hg) fell by 274 6 27% (p , 0.001), with
an increase in mean CoA diameters of 128 6 128% in the left anterior oblique and 124 6
87% in the lateral views (p , 0.001). Two deaths occurred, one at the time of the procedure
and one 23 months later, both as a result of an associated cardiomyopathy. Seven patients had
residual gradients of .20 mm Hg. One patient developed an aneurysm, stable in follow-up,
and four patients had mild dilation at the site of the angioplasty. Freedom from reintervention
was 90% at one year and 87% at five years with follow-up ranging to 8.5 years. Factors
significantly associated with decreased time to reintervention included: a higher gradient
before dilation, a smaller percentage change in gradient after dilation, a small transverse arch
and a greater stretch and gain, but not recoil.
CONCLUSION Balloon dilation is a safe and efficient treatment of native CoA in children. Greater stretch
and gain are factors significantly associated with reintervention, possibly related to altered
elastic properties and vessel scarring. (J Am Coll Cardiol 2000;35:988–96) © 2000 by the
American College of Cardiology
Percutaneous balloon angioplasty of unoperated or native
coarctation of the aorta (CoA), first described by Singer et
al. (1) appears a viable, although controversial, management
option. Clinical concerns regarding potential weakening of
the aortic wall, aneurysm formation and recurrence exist (2).
The largest clinical studies currently available, with
follow-up up to nine years, describe aneurysm formation in
,5% of patients (3–5), with their development potentially,
although not convincingly, related to intrinsic vessel wall
abnormalities more than to the extent of the vessel wall tears
(6,7). Young patient age (neonates) and the presence of
associated transverse aortic arch hypoplasia have been asso-
ciated with a higher incidence of recurrence (3–5,8). To this
end, the elastic properties of the aortic vessel wall, as studied
by the stretch-recoil-gain relationships, may also influence
immediate and long-term response to balloon angioplasty
(9,10).
In this study, we reviewed our clinical experience with
balloon angioplasty of native CoA, detailing immediate and
late outcomes and complications. Age, hemodynamic data,
aortic arch measurements and biophysical characteristics of
the vessel wall were further analyzed as possible factors
associated with long-term success.
METHODS
Indications for intervention. From June 1988, patients
presenting with a discrete CoA and a resting systolic
gradient by sphygmanometry between the upper and lower
limbs of .20 mm Hg were offered balloon angioplasty as an
alternative to surgery (2). Neonates and young infants (,1
year of age) were not, on a routine basis, considered for
transcatheter treatment.
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Technique. General anesthesia was used in all procedures.
The initial approach to the procedure was a right heart
catheterization followed by transseptal entry to the left
atrium. A balloon tipped catheter (Berman, Arrow Interna-
tional, Reading, Pennsylvania) was directed into the left
ventricle and ascending aorta, from where an aortogram was
obtained (1–2 cc/kg, Hexabrix, Mallinkodt Inc. or Isovue,
Bracco Diagnostics, Ontario) in the 15°–20° left anterior
oblique (LAO) and lateral (LAT) angiographic projections.
Occasionally, to improve the lesion profile due to overlap of
the isthmus upon the descending aorta, a caudal tilt (10° to
20°) was used on the LAO projection. Subsequently, an
arterial catheter was placed from a retrograde approach,
simultaneous ascending and descending aortic pressures
obtained and the angioplasty performed. An 0.035 in,
260 cm exchange guide wire (Cook Inc., Bloomington,
Illinois) was placed through an end hole catheter positioned
above the aortic valve and maintained in the ascending aorta
throughout the procedure. The balloon catheters were
inserted over this wire without a vascular sheath. The
transatrial catheter in the ascending aorta allowed continual
arterial pressure monitoring and repeat aortography to judge
the anatomic impact of the procedure, avoiding arterial
catheter exchange and thereby lessening trauma to the
femoral vessel. Patients were administered 150 IU/kg of
heparin sulfate intravenously after vascular access was
achieved, (maximum dose 5,000 IU), with an additional
dose of 75 IU/kg given if the duration of the study exceeded
2 h. Activated clotting times were not measured.
The initial balloon diameter was chosen to be equal to or
within 1 to 2 mm of the diameter of the aorta at the level of
the subclavian artery and not greater than the diameter of
the aorta at the diaphragm. Short inflation times were
employed (,10 s) but repeated (two to four times) before
repeat aortography was obtained. If no significant change in
lesion diameter was noted (a diameter increase within 80%
to 90% of the diameter of the aortic isthmus), the next larger
balloon diameter was used within the above guidelines.
One hour after the conclusion of the procedure, an
intravenous heparin sulfate infusion was begun if the pedal
arterial pulse was absent. Administered was a bolus of
75 IU/kg followed by an intravenous infusion at 20 IU/
kg/h, adjusting the activated partial thrombin time to
between 60 to 100 s. The infusion was maintained for 24 h,
and thrombolytic therapy was administered if the pulse did
not return (11).
Informed consent was obtained from all patients in
accordance with the Human Subjects Protection Commit-
tee of the Hospital for Sick Children, University of To-
ronto.
Data collection, measurements and calculations. Cardiac
catheterization data. Invasive blood pressures were mea-
sured above and below the areas of CoA before and after
balloon dilation, as well as the maximal balloon size em-
ployed. The clinical impact of all complications was also
noted.
Aortic arch measurements. All cineangiograms were re-
viewed, and the diameters of the following regions were
recorded prior to angioplasty: ascending aorta, transverse
aortic arch (between the brachiocephalic and left common
carotid arteries), isthmus (area beyond the left subclavian
artery), the CoA site and the descending aorta at the level of
the diaphragm and after the procedure: transverse aortic
arch, isthmus and CoA site. All measurements were from
systolic frames and corrected for magnification using the
known diameter of the angiographic catheter.
Assessment of transverse arch hypoplasia. Transverse aortic
arch dimensions were normalized to aortic arch dimensions
previously obtained from age-matched controls without
aortic pathology at our institution (unpublished data).
Transverse aortic arch hypoplasia was defined as a transverse
aortic arch z-score ,22.
Biophysical measurements. Balloon inflation stretches the
CoA segment. As a result of elasticity of the vessel wall, it
recoils, determining the vessel dimension after dilation. The
gain is the difference between pre- and post-angioplasty
dimensions (induced enlargement). The stretch-recoil-gain
relationship for the cross-sectional area and circumference
of the CoA segment were calculated. The fully inflated
balloon was considered as a perfect circle (area 5 pi r2,
circumference 5 2 pi r). As the balloons were inflated to
within rated pressures by hand until the CoA waist disap-
peared, the nominal balloon diameters were used in the
calculations. The CoA segment was considered an ellipse,
using the measured diameters in the LAO and the LAT
angiographic projections for calculations of area (5 pi ab)
and circumference (5 4aE; E being derived from a table of
elliptic integrals, based on a k value 5 square root a2 2 b2/a,
a being the largest diameter of the ellipse) (12). Area and
circumference stretch was calculated as the difference be-
tween the inflated balloon dimensions and those of the CoA
segment before angioplasty, normalized to the balloon
dimensions. Area and circumference recoil was calculated as
the difference between the inflated balloon dimensions and
those of the CoA segment after balloon angioplasty, nor-
malized to the balloon dimensions. Gain was calculated as
the difference between area or circumference of the CoA
segment before and after angioplasty, normalized to the area
or circumference before balloon angioplasty. All values were
multiplied by 100 to calculate percent stretch, recoil and
gain (Fig. 1, Table 1).
Abbreviations and Acronyms
CoA 5 coarctation of the aorta
LAO 5 left anterior oblique
LAT 5 lateral
MRI 5 magnetic resonance imaging
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Follow-up. Patients were followed as clinically indicated.
Sphygmanometric blood pressure measurements in the right
arm and the noncatheterized leg were performed at each
follow-up visit. The morphology and dimensions of the
thoracic aorta were assessed by magnetic resonance imaging
(MRI) or by repeat angiography in 61 patients (90%). An
aneurysm of the aorta at the site of the dilation was defined
as the presence of wall contour deformation, whose diam-
eter was 1.5 times the aorta at the level of the diaphragm
(13,14). Magnetic resonance imaging was performed in a
1.5 Tesla superconducting magnetic scanner, using a spin
echo technique with cardiac gating and respiratory compen-
sation. Imaging which eluded axial, oblique coronal and
oblique sagittal planes with 5 mm thick images were
obtained with 1 mm interspersing. In addition, gradient
recalled acquisition scanning of the pelvic vessels was carried
out in an axial plane in 23 of 68 patients (34%) (15).
Success. Early success was defined as a reduction in the
sphygmanometric blood pressure gradient between the up-
per and lower limbs ,20 mm Hg, precluding the need for
early reintervention (,1 year). Long-term success was
defined as a compound outcome of an arm to leg gradient by
sphygmanometry of ,20 mm Hg and freedom from rein-
tervention.
Data analysis. Patient and procedural characteristics were
described as frequencies, medians with ranges and means
with standard deviations as appropriate. Where there were
missing data, the number of nonmissing values was reported
for that variable. All statistical analyses were performed
using SAS Version 6.12 statistical software (SAS Institute,
Inc., Carey, North Carolina) using default settings.
Changes in hemodynamic parameters and vascular dimen-
sions were tested with paired t tests. The proportion of
patients with an immediate (during cardiac catheterization)
residual peak-to-peak systolic pressure gradient across the
obstruction of 20 mm Hg or more, and the proportion of
patients that needed early versus late reintervention were
noted. Factors associated with acute procedural outcomes
were sought with t tests and Kruskal-Wallis analysis of
variance. Outcomes during follow-up were described, and
estimates of freedom from reintervention for residual or
recurrent obstruction were plotted as Kaplan-Meier curves.
The association of patient and procedural characteristics,
acute results and biophysical parameters with freedom from
reintervention were each tested in univariable Cox’s propor-
tional hazard regression modeling. A p , 0.05 was set as the
level of statistical significance.
RESULTS
Patient characteristics. From June 1988 through Decem-
ber 1996, 74 patients underwent transcatheter treatment of
native CoA. Of the 74 patients, 69 underwent balloon
dilation and five patients underwent endovascular stent
placement. Those five patients are not described in this
study and were excluded from further analyses.
Of the 69 patients, 46 were male (67%) and 23 were
female (33%). A bicuspid aortic valve was present in 42
patients (61%). Other associated cardiac anomalies are
described in Table 2. The median patient age at procedure
was 5.8 years (range, six months to 16.8 years). Only three
Figure 1. Representation of the measurements of the CoA before
and after angioplasty (ellipse) and of the fully inflated balloon
(circle).
Table 1. Formulas for Calculation of Stretch, Recoil and Gain
% Circumference Stretch 5
Balloon circumference 2 CoA circumference pre
Balloon circumference
3 100
% Area Stretch 5
Balloon area 2 CoA area pre
Balloon area
3 100
% Circumference Recoil 5
Balloon circumference 2 CoA circumference post
Balloon circumference
3 100
% Area Recoil 5
Balloon area 2 CoA area post
Balloon area
3 100
% Circumference Gain 5
CoA circumference post 2 CoA circumference pre
CoA circumference pre
3 100
% Area Gain 5
CoA area post 2 CoA area pre
CoA area pre
3 100
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patients were ,1 year, the youngest being 6 months of age,
presenting with severe left ventricular failure. The median
weight at intervention (n 5 68) was 19 kg (range, 8 to
64 kg), with a median height (n 5 68) of 112 cm (range, 69
to 177 cm).
The mean z-value for the transverse aortic arch (n 5 63)
was 21.66 6 1.48 (p , 0.001 vs. normal) with hypoplasia,
as defined above, noted in 46% of the patients.
Early results. Median balloon diameter was 12 mm (range,
7 to 20 mm), with a mean ratio of balloon to isthmus
diameter (n 5 58) of 1.2 6 0.4, a mean ratio of balloon to
aortic diameter at the level of the diaphragm of 1.0 6 0.2
and a mean ratio balloon to CoA segment diameter (n 5
65) of 3.1 6 1.3.
Hemodynamic and angiographic data before and after
angioplasty, expressed as mean values 6 1 standard devia-
tions, are shown in Table 3. The systolic pressure gradients
across the CoA sites and the ratio between the peak systolic
pressures in the ascending and the descending aorta de-
creased significantly after angioplasty, with mean percentage
changes, respectively, of 274 6 28% (n 5 67, p , 0.001)
and 221 6 9% (n 5 67, p , 0.001).
The dimensions of the CoA segments, as well as the ratio
of diameters of the CoA segments to diaphragmatic aorta
from both angiographic projections (LAO, LAT), increased
significantly, with mean percentage increases, respectively,
of 129 6 29% (n 5 62, p , 0.001) and 124 6 87% (n 5
66, p , 0.001).
Biophysical data: the stretch-recoil-gain relationships.
Mean circumferential stretch was 63 6 14% (n 5 64), mean
circumferential recoil 26 6 12% (n 5 63) and mean
circumferential gain 123 6 96% (n 5 61). Mean area
stretch was 84 6 12% (n 5 64), mean area recoil 44 6 20%
(n 5 63) and mean area gain 493 6 706% (n 5 65).
The relation between stretch, gain and recoil for areas and
circumferences are represented in Fig. 2. There was an
exponential increase in area and circumference gain with
stretch. There was no relation between area or circumfer-
ence recoil and stretch.
Early complications. One patient (1%) aged six months
died during the procedure as a result of severe left ventric-
ular failure, its severity having precluded a surgical repair.
Five patients (7%) had reduced pulses in the catheterized leg
treated with heparin sulfate with reappearance of the pulse
in all cases. Three additional patients (4%) had mildly
reduced pulses in the catheterized leg but were not treated.
One patient had to be admitted to the intensive care unit for
control of elevated blood pressure (paradoxical hyperten-
sion). Nine others required intravenous, sublingual or oral
therapy to control elevated blood pressures after the proce-
dure (15%). Seven of those, plus two additional patients
were prescribed oral antihypertensive treatment at the time
of hospital discharge. Two patients (3%) had a transient
Table 2. Associated Cardiac Lesions
N %
Bicuspid Aortic Valve 42 61
Associated intracardiac anomalies 21 30
Aortic valve stenosis 6
Ventricular septal defect 7
Subaortic stenosis 8
Transposition of the great arteries 1
Mitral valve anomaly 3
Other cardiovascular anomalies 12 17
Patent arterial duct 7
Persistent left superior vena cava draining
to the coronary sinus
3
Aberrant origin of the left subclavian
artery
2
Severely reduced left ventricular function at
presentation
4 6





Pressure gradient (mm Hg) 31 6 12 8 6 8 , 0.001
(n 5 67) (n 5 68) (n 5 67)
Ascending/descending aortic systolic pressure ratio 1.39 6 0.21 1.09 6 0.10 , 0.001
(n 5 67) (n 5 68) (n 5 67)
CoA dimension (LAO projection) (mm) 4.6 6 2.7 8.9 6 3.1 , 0.001
(n 5 65) (n 5 64) (n 5 62)
CoA dimension (LAT projection) (mm) 4.8 6 29 9.2 6 2.9 , 0.001
(n 5 68) (n 5 66) (n 5 66)
CoA/diaphragmatic aorta diameter
ratio (LAO projection)
0.36 6 0.14 0.70 6 0.15 , 0.001
(n 5 65) (n 5 64) (n 5 62)
CoA/diaphragmatic aorta diameter
ratio (LAT projection)
0.36 6 0.14 0.72 6 0.14 , 0.001
(n 5 68) (n 5 66) (n 5 66)
CoA 5 coarctation; LAO 5 left anterior oblique view; LAT 5 lateral view.
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episode of junctional escape rhythm not requiring treat-
ment.
Early failure. In seven patients (10%), the procedure was
not successful. Six of these patients underwent early rein-
tervention (,1 year), and one patient was managed with
oral antihypertensive treatment and underwent reinterven-
tion at a later stage (see below). Table 4 compares the
hemodynamic and angiographic data between patients with
early success and those with early failure. Patients with early
success had significantly lower gradients and ascending to
descending aortic systolic pressure ratios measured inva-
sively at catheterization before dilation, with greater ratios
of balloon to coarctation and to diaphragmatic aortic diam-
eters. Patients with successful procedures had somewhat
lower circumferential and cross-sectional area stretch and
significantly lower gain, but did not differ regarding recoil.
In multiple logistic regression analysis, only a lower systolic
pressure ratio (odds ratio [OR] 0.65 per 0.1 decrease; 95%
confidence interval [CI] 0.45 to 0.95; p 5 0.03) and a
greater ratio of balloon to diaphragmatic aortic diameter
(OR 0.44 per 0.1 increase; 95% CI 0.22 to 0.89; p 5 0.03)
could be entered significantly into the final model. After
controlling for these two variables, no other variable was
significantly independently associated with early success.
Reintervention. Nine of the 68 early survivors (13%)
required reintervention at a median interval of 7.7 months
(range, 1.2 months to 7.6 years) after the initial procedure.
Reasons for reintervention included an unsuccessful initial
procedure in seven (10%) and a recurrent stenosis despite an
initially successful procedure in two patients (3%). One
patient with an initially unsuccessful procedure had a repeat
balloon angioplasty (using a larger balloon) with clinical
success. In two other patients, presence of vessel dilation
around the site of restenosis precluded repeat balloon
dilation and these, together with four additional patients,
were referred for surgery. The two patients with late
restenosis had successful repeat transcatheter treatment,
including one patient in whom an endovascular stent was
placed across the recoarcted segment.
Follow-up. Of the 61 early survivors with an initially
successful procedure, two were lost to follow-up. For the
remaining 59 patients, median clinical follow-up interval
was 2.8 years (range, 2.4 months to 8.5 years). Two patients
underwent reintervention (repeat transcatheter angioplasty,
as described above) for late restenosis, both seven years after
the initial procedure. One late death occurred 23 months
after the initial procedure in a child with persistent severe
left ventricular dysfunction, despite the absence of residual
or recurrent coarctation after the balloon angioplasty.
For the remaining 56 patients, mean systolic pressure in
the right arm at latest clinical follow-up assessment was
110 6 12 mm Hg. Nine patients had required antihyper-
tensive therapy after the angioplasty, but none were being
treated at latest follow-up. The median systolic gradient
between the right arm and the noncatheterized leg at latest
clinical visit (n 5 49) at a median interval after the initial
Figure 2. Relation between gain and stretch for area (A) and circumference (B) and relation between recoil and stretch for area (C) and
circumference (D). Reint 5 reintervention. Closed diamond 5 No Reint; open square 5 Reint.
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procedure of 2.6 years (range, 2.4 months to 8.5 years) was
5 mm Hg (range, 220 to 40 mm Hg). A gradient of
$20 mm Hg was noted in three patients. In two of these
patients, MRI revealed no significant recoarctation, and, in
the absence of associated hypertension, conservative man-
agement was advocated. The remaining patient had a
cardiac catheterization, and was noted to have a diffusely
tortuous aorta (invasive gradient, 14 mm Hg), and no
further treatment was recommended.
Aneurysm formation. The morphology and dimensions of
the thoracic aorta were assessed during follow-up in 61 of
the 68 (90%) early survivors, by MRI (n 5 60) or by repeat
angiography (n 5 9), with the latest assessment being
performed at a median of 6 months (range one week to 3.5
years) after the initial balloon angioplasty. One patient (1%)
had an aneurysm diagnosed by MRI and confirmed by
angiography. This aneurysm remained stable in size over the
time of observation, and no intervention was required. Four
patients (7%) had mild dilation of the aorta at the angio-
plasty site (not fulfilling the criteria for an aneurysm)
without progression over the period of observation. Two
additional patients (3%) who required reintervention for
residual stenosis had mild dilation at the angioplasty site. In
three further patients (5%), early MRI studies showed an
intimal flap within the vessel lumen but no aneurysm or
dilation. Repeat MRI in those three patients showed dis-
appearance of the intimal flap in two patients, with the
remaining patient having an unusual form of vasculopathy
(16).
MRI assessment of femoral artery patency. Twenty-one
patients had early MRI assessment of femoral artery pa-
tency. Iliofemoral arteries were described as normal in 7
patients, patent but significantly smaller than the contralat-
eral vessel in 10 and blocked or severely stenosed in 4
Table 4. Comparison of Patients With Early Failure Versus Success
Early Failure (n 5 7) Early Success (n 5 61) p Value
Median age at intervention (yr) 7.8 5.8 0.54
(1.1 to 14) (0.8 to 16.8)
Median weight at intervention (kgs) 26.3 19 0.70
(8.2 to 54) (8 to 64.5)
Mean transverse aortic arch z-value 22.59 6 0.74 21.57 6 1.50 0.11
(n 5 6; p , 0.001*) (n 5 57; p , 0.001)
Mean peak-to-peak systolic ascending to descending aorta
pressure gradient before dilation (mm Hg)
41 6 13 29 6 11 0.01
(n 5 60)
Mean ratio of peak systolic ascending to descending
aortic pressure before dilation
1.59 6 0.17 1.37 6 0.20 0.006
(n 5 60)
Median diameter of CoA segment in LAO projection (mm) 3.6 3.8 0.08
(1 to 4) (2 to 12)
(n 5 57)
Median diameter of CoA segment in LAT projection (mm) 2.5 4 0.07
(1.4 to 6) (1.8 to 15)
Mean ratio of balloon diameter to:
Aortic isthmus diameter 1.18 6 0.31 1.24 6 0.39 0.73
(n 5 5) (n 5 52)
CoA diameter 4.56 6 2.58 2.98 6 1 0.003
(n 5 57)
Aorta at diaphragm diameter 0.83 6 0.15 0.98 6 0.13 0.008
Mean circumferential:
Stretch 71 6 10% 62 6 14% 0.07
(n 5 57)
Recoil 27 6 12% 26 6 13% 0.81
(n 5 6) (n 5 57)
Gain 218 6 204% 112 6 73% 0.01
(n 5 6) (n 5 55)
Mean cross-sectional area:
Stretch 91 6 6% 84 6 12% 0.11
(n 5 57)
Recoil 48 6 17% 44 6 21% 0.69
(n 5 6) (n 5 57)
Gain 1,250 6 1,915% 410 6 379%
(n 5 6) (n 5 55) 0.005
*p value represents single sample t test versus a hypothesized population mean of 0.
CoA 5 coarctation; LAO 5 left anterior oblique view; LAT 5 lateral view.
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patients. Fourteen patients had a follow-up study of the
femoral arteries, showing normal vessels in five patients,
patent but smaller illiofemoral arteries in five and severely
stenosed or blocked arteries in four patients. Out of 12
patients who had two MRI assessments of the femoral
arteries, there was no change or progression between the
two assessments in 10 patients. In one patient there was
progression from a normal appearing artery to a severely
stenosed artery, and in one patient there was progression
from a narrow but patent artery to a severely stenosed or
blocked artery.
Freedom from reintervention. Kaplan-Meier estimates of
freedom from reintervention in early survivors were 90% at
one year and 87% at five years (Fig. 3). Factors associated
with a decreased time to reintervention were sought in
univariable Cox’s proportionate hazard modeling (Table 5).
Significant factors included a lower z-value of the transverse
aortic arch diameter, higher predilation ascending to de-
scending aortic peak-to-peak systolic pressure gradient, a
lower percentage change in invasive gradient with dilation,
a higher ratio of balloon to coarctation segment diameter
but a lower ratio of balloon to aorta at level of diaphragm
diameter and both increased circumferential and cross-
sectional area stretch and gain, but not recoil. In stepwise
multiple Cox’s proportionate hazard regression modeling,
only three variables were independently associated with a
reduced time to reintervention (n 5 57) and included a
higher predilation invasive gradient, a reduced percentage
change in invasive gradient with dilation and an increased
ratio of balloon to coarctation segment diameter. After
controlling for these three variables, no other variable met
level of significance criteria for entry into the final model.
DISCUSSION
Transcatheter treatment of native CoA in children remains
a highly charged and controversial topic due to the perceived
risks to vessel integrity, its influence on long-term vessel
stability and the initial success of the procedure (2). In this
regard, a more coherent understanding of the mechanism of
restenosis and aneurysm formation, as well as longer term
follow-up of results after angioplasty, can help toward
resolving this management dilemma.
Factors associated with restenosis after balloon angio-
plasty have been described in many large studies and
include: young patient age (neonate), associated arch hy-
poplasia and a small CoA diameter (3–5,8,17). Aneurysm
formation, although in some cases related to technical
factors such as use of larger balloons, may be promoted by
inherent wall abnormalities such as cystic medial necrosis
(7,18). The presence of ductal tissue within the aortic wall
as seen in neonates may be an important component of
Figure 3. Kaplan-Meier plot of freedom from reintervention after
initial transcatheter balloon angioplasty. Dashed lines represent
95% confidence intervals.
Table 5. Factors Associated With Decreased Time to Reintervention*
n
Beta Coefficient
(Standard Error) p Value RR (95% CI)
Age at intervention (yr) 66 20.0513 (0.0842) 0.55 0.95 (0.81, 1.12)
Weight at intervention (yr) 66 20.0209 (0.0237) 0.38 0.98 (0.93, 1.03)
z-value of transverse aortic arch diameter 61 20.9667 (0.3962) 0.02 0.38 (0.17, 0.83)
Ascending to descending peak-to-peak systolic pressure
gradient predilation (mm Hg)
65 0.0818 (0.0293) 0.006 1.09 (1.02, 1.15)
Percentage change in invasive gradient 64 0.0305 (0.0083) , 0.001 1.03 (1.01, 1.05)
Ratio of balloon to CoA segment diameter 62 0.3979 (0.1379) 0.004 1.45 (1.14, 1.95)
Ratio of balloon to aorta at level of diaphragm diameter 66 25.7089 (2.6201) 0.03 0.003 (0.00002, 0.56)
Circumferential stretch (%) 62 0.0845 (0.0366) 0.02 1.09 (1.01, 1.17)
Circumferential recoil (%) 61 0.0364 (0.0331) 0.28 1.04 (0.97, 1.11)
Circumferential gain (%) 59 0.0049 (0.0021) 0.02 1.01 (1.00, 1.02)
Cross-sectional area stretch (%) 62 0.1289 (0.0634) , 0.05 1.14 (1.00, 1.29)
Cross-sectional area recoil (%) 61 0.0275 (0.0228) 0.23 1.03 (0.98, 1.07)
Cross-sectional area gain (%) 59 0.0005 (0.0002) 0.03 1.00 (1.00, 1.00)
*From univariable Cox’s proportionate hazard modeling.
CI 5 confidence interval; CoA 5 coarctation; RR 5 risk ratio.
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restenosis when balloon dilation is applied in this age group
(17).
Our results are very similar to those of previously reported
studies. Early success was achieved in 87% of the patients.
Complications were rare and mainly related to femoral
artery damage and paradoxical hypertension. Aneurysm
formation occurred in only 1% of the patients in whom
MRI or angiography was performed during follow-up, but
an additional 7% had vessel irregularities, albeit stable in
size, at the dilation site. Longer follow-up remains impor-
tant in such patients. Reintervention was required in 13%,
and factors associated with reintervention reported in pre-
vious studies were also found to be significant in our study:
a high predilation gradient, a reduced percentage change in
invasive gradient with dilation and an increased ratio of
balloon to coarctation segment diameter were associated
with a decreased time to reintervention. Age was not a
factor, but most of our patients were .1 year of age. Repeat
angioplasty, including stent placement in one patient, was
performed successfully in three out of the nine patients
requiring reintervention, the remainder (n 5 6) having
uncomplicated surgical reintervention.
The biophysical properties of the vessel wall may also play
an important role in the response to balloon dilation. To
better predict the response of atheromatous coronary arter-
ies to balloon angioplasty, Rensing et al. measured the
stretch-gain-recoil relationship during angiography as a
marker of the biophysical properties of the coronary vessel
wall (19,20). They reported that greater gain was associated
with more severe luminal narrowing at follow-up and
hypothesized that extensive damage caused by dilation
(greater gain) promoted intimal hyperplasia and prolifera-
tion of muscle cells responsible for restenosis (20). Ino et al.
used the same approach to study the aortic vessel wall in
patients undergoing balloon dilation of CoA and found that
greater stretch and gain was associated with late restenosis
(9). However, their patient group was heterogeneous, in-
cluding those with native CoA and recurrent CoA after
surgical repair, infants, young children and adolescents.
Such divergent populations may have different vessel wall
properties influencing vessel response to dilation. Rao et al.
(10) applying a similar method of assessment to CoA, found
that recoil was greater in the group without restenosis. Their
hypothesis was that in the group with recurrent stenosis
after dilation, the elastic properties of the wall had not been
preserved, thereby causing restenosis. However, in their
analysis, the method of calculation of stretch, gain and recoil
was different than that used by Ino et al. (9) making
comparisons difficult.
Our cohort included only patients with native CoA and
excluded neonates and young infants. Stretch, recoil and
gain were measured from CoA cross-sectional areas as well
as circumference, suggested by Rao et al. (10). However, as
in Ino et al.’s study (9), stretch and recoil were normalized
to the balloon diameters and gain normalized to the CoA
dimensions before dilation, to minimize the effect of body
size. Also considered was the geometry of the CoA, being
closer to an ellipse than to a circle, for calculation of the
CoA cross-sectional areas and circumferences, using the
dimensions measured from two nearly orthogonal projec-
tions. Thus, it is difficult to compare our findings with the
previously described studies (9,10). However, as did Ino et
al. (9), we found an exponential relationship between gain
and stretch. Reasonable cross-sectional area gain seems to
be obtained with an area stretch between 80% and 90% and
a reasonable circumferential gain with a circumferential
stretch between 60% and 70%. Similarly, we found that
larger gain and stretch were significantly associated with
early failure and reintervention, while recoil was not found
to be associated with reintervention. However, one critical
difference between Ino’s study and ours was that seven of the
nine patients who underwent reintervention did so for an
unsuccessful procedure, therefore representing the effect of
residual stenosis rather than late restenosis or recurrence.
The small group of patients with late restenosis (n 5 2)
precludes meaningful analysis. The hypothesis that greater
gain and stretch, by promoting more extensive vessel dam-
age, produces more intimal hyperplasia and, thus, late
restenosis was difficult to confirm in this group of patients.
Greater gain and stretch could, however, alter elastic prop-
erties and favor residual stenosis. Our results may also
simply reflect the notion that severe coarctations, in which
stretch and gain would be expected to be more important,
are more difficult to dilate due to their smaller circumference
compared with that of the normal aortic wall. Furthermore,
the morphology of the obstructing shelf may importantly
impact dilation results, not influenced by the elasticity of the
vessel, but the histological features of the shelf, where a
more inelastic shelf may be more easily torn than a more
compliant one. In those patients with the most severe
obstructive lesions, there appeared to be more of an invag-
ination of the wall rather than an intraluminal shelf, which
could be enlarged through dilation (tearing) within the
shelf. More studies on larger populations with residual and
late restenosis will be required to fully determine and
understand the possible impact of stretch, gain and recoil on
outcome. Finally, small measurement errors in the area and
circumference normalization can effect results. To limit this
effect, an elliptical lesion model was used (rather than
assuming a circular lesion) and multiple measurements of
the lesion taken in optimal orthogonal projections.
In conclusion, our study supports the previous studies
showing that balloon dilation is a safe and effective treat-
ment option for native CoA in children after infancy.
Reintervention was more likely when the initial coarctation
gradient was very high and when there was associated
transverse aortic arch hypoplasia. Modification of vessel wall
properties were reflected by the stretch-recoil-gain relation-
ship, which might be an important prognostic factor for
outcome, but more data are necessary to sustain this
hypothesis and fully understand the mechanism.
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